HAMP and anemia (phenotype): Hepcidin inhibitors improved inflammation driven alterations of iron homeostasis or ameliorated anemia in animal models but also in humans, mainly by mobilization of iron from macrophages (Sasu et al., 2010; Theurl et al., 2011b; Boyce et al., 2016; Khorramian et al., 2017; Petzer et al., 2020).